Abingdon, United Kingdom

Christofe Fromont

This inventor holds 2 USPTO granted patents. Top assignees: Cancer Research Technology Limited, The Institute of Cancer Research, Vernalis (Cambridge) Limited. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christofe Fromont. Retrieved from https://idiyas.com/inventor/christofe-fromont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christofe Fromont: Innovator in Cancer Research

Introduction

Christofe Fromont is a notable inventor based in Abington, GB. He has made significant contributions to the field of cancer research through his innovative work and patents. With a total of 2 patents, his research focuses on developing inhibitors that can potentially aid in cancer treatment.

Latest Patents

Christofe Fromont's latest patents include "Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors." These compounds are designed to inhibit HSP90 activity both in vitro and in vivo, showcasing their potential use in treating various forms of cancer. The compounds are characterized by a specific formula that includes various radicals and groups, indicating their complex chemical structure and functionality.

Career Highlights

Throughout his career, Christofe has worked with prominent organizations such as Cancer Research Technology Limited and the Institute of Cancer Research. His work in these institutions has allowed him to contribute to groundbreaking research in the fight against cancer.

Collaborations

Some of his notable coworkers include Brian William Dymock and Martin James Drysdale. Their collaborative efforts have likely enhanced the research outcomes and innovations in their respective fields.

Conclusion

Christofe Fromont's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…